Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Open in API
Filings indexed 1,983 across all filing types
Latest filing 2024-06-14 Regulatory Filings
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-06-14 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled "INDIVIOR PLC TRANSACTIONS IN OWN SHARES" and details the purchase of ordinary shares for cancellation on June 13, 2024. It provides specific details on the number of shares purchased, VWAP, and a full breakdown of individual transactions. This content directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category. Filing Code Match: POS (Transaction in Own Shares).
2024-06-14 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-06-13 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled "INDIVIOR PLC TRANSACTIONS IN OWN SHARES" and details the purchase of ordinary shares for cancellation on June 12, 2024. It provides aggregated volume and VWAP data, along with a full breakdown of individual purchases. This content directly corresponds to the definition of a company reporting transactions involving its own shares (share repurchase program). This matches the definition for 'Transaction in Own Shares' (POS). The RNS Number (2274S) indicates it is a regulatory announcement, but the specific content points strongly to POS over the general RNS category.
2024-06-13 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-06-12 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled "INDIVIOR PLC TRANSACTIONS IN OWN SHARES" and details the purchase of ordinary shares for cancellation on June 11, 2024. It explicitly mentions the number of shares purchased, the prices, and the resulting total shares outstanding. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category. This matches the definition for Transaction in Own Shares (Code: POS). It is not a general regulatory filing (RNS) because it is highly specific, nor is it a major shareholding notification (MRQ) as it reports the company's own actions, not an external shareholder's change in interest (though it does provide the denominator for MRQ calculations).
2024-06-12 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.